Delivery Order SPE2DB22D1017-SPE2DB24FE7LQ
- Not listed
- This federal contract award, valued at $12,110.81, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DIOVAN HCT 320-12.5 MG TAB 90S, a pharmaceutical product, with an ultimate completion date of April 24, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type. The award is not associated with a set-aside designation, indicating open competition....
- This federal contract award, valued at $2,994.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4559849311 - DIOVAN HCT 320-12.5 MG TAB 90S, a cardiovascular medication. The award was made on a firm fixed-price basis with a completion date of February 7, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $19,549.83, is for the delivery of 4562216917 - DIOVAN HCT 320-12.5 MG TAB 90S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 19, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award, valued at $1,214.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4568172510 DIOVAN HCT 320-12.5 MG TAB 90S, a prescription medication, with a completion date of May 8, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite...
- This federal contract award, valued at $10,296.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562086287 DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication, with a completion date of September 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $5,470.62, is for the delivery of Diovan HCT 320-12.5 mg tablets. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award, valued at $14,876.00, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a total potential value of $999,999,999.00 and runs through November 2026. The contract is for the delivery of DIOVAN HCT 320-25 MG TABLET 90S, a cardiovascular medication. The award does not have a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Diovan HCT 320-12.5 mg tablets. The Firm Fixed Price delivery order, valued at $3,206.54, has a completion date of June 12, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $16,181.67 firm-fixed-price delivery order is for the supply of DIOVAN HCT 320-12.5 MG TAB 90S, a medication used to treat high blood pressure. The contract has a completion date of July 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- This federal contract award is a delivery order with a ceiling value of $2,901.08, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The award covers the procurement of DIOVAN HCT 320-12.5 MG TAB 90S, a pharmaceutical product used for cardiovascular health. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FE7LQDelivery Order
This federal contract award, valued at $4,262.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of DIOVAN HCT 320-12.5 MG TAB 90S, a pharmaceutical product. The contract has an ultimate completion date of October 24, 2023 and is a firm fixed-price delivery order. The contract was awarded without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000.00, for the provision of a wide range of pharmaceutical products and medical supplies to support government healthcare programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 10/23/23 |